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Human thymus-derived lymphocytes proliferate when 
cultured with lymphocytes or epidermal cells from un-
related individuals because such cells express HLA-D 
antigens, which are recognized as foreign by thymus-
derived lymphocytes. The current study d emonstrates 
that these responses are inhibited if e ither the stimulator 
cells or responder cells are pretreated with the combi-
nation of 8-methoxypsoralen and long-wave ultraviolet 
light. Additional studies revealed that photoactivated 8-
methoxypsoralen has a lethal effect on lymphocytes and 
monocytes but not on the majority of epidermal cells. 
These observations suggest that the dramatic beneficial 
effect of PUV A on patients with psoriasis and other skin 
disorders may be due to a toxic effect on immunocom-
petent cells in the epidermis, which results in inhibition 
of cell mediated immune responses. 
The discovery tha t combined therapy with 8-methoxypsora-
len (8-MOP) and long-wave ultraviolet light (UV A) has dra-
matic beneficial effects on psoriasis has led to increasing clinical 
use of this treatment, which is known as PUVA [1]. Previous 
reports indicated that PUVA inhibi tS cellula1· DNA synthesis, 
both in vitro [2] and in vivo [3], and these observations provided 
the rationale for the use of P UV A in psoriasis, a disease char-
acterized by epidermal cell hyperproliferation. The hypothesis 
that PUV A works by inhibit ing abnormal cellular prolifera tion 
may be valid, but it does not adequately explain the beneficial 
effects of PUVA in vitiligo [ 4], alopecia areata [5], mycosis 
fungoides [6] and lichen planus [7] , none of which ar e charac-
t erized by rapid tmnover of epidermal cells. Moreover, recent 
data indicate that the pathogenesis of at least some of these 
conditions may involve immune mechanisms [8,9], prompting 
the suggestion that PUV A may work by inf1uencing host im-
mune fun ctions [10]. 
This s tudy is an effort to determine the effects of PUV A on 
immunologic reactions eljcited by HLA-D an tigens. These an-
t igens ar e expressed by only a few cell types, including lympho-
cytes [11], monocytes [11], cer tain bone marrow precursor cells 
[12] and Langerhans (Lh) cells whlch represent 2-4% of the 
cells of the epidermis [13]. To test for the presence of HLA-D 
a ntigens, lymphocytes of one individual are incubated for sev-
eral days with x-u-radiated lymphocytes of another donor in the 
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MLR: mixed lymphocyte reaction 
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P BML: peripheral blood mononucleru· leukocytes 
P UVA: 8- methoxypsoralen combined with long wave ul traviolet 
ligh t 
UV A: long-wave ultraviolet light 
UVB: short-wave ul traviolet light 
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one-way mixed lymphocyte reaction (MLR) [14]. In the epider-
mal cell-lymphocyte reaction (ELR), epidermal cells are sub-
sti tuted for the ilTadiated lymphocytes and serve as the stin1-
u1at ing cell population [15,16]. In the ELR, as in the MLR, 
thymus-derived (T) lymphocytes proliferate in response to for-
eign HLA-D ant igens present on the sw·face of stimulating cells 
[17]. In the cmrent study, we assess the effects of P UVA on the 
capacity of epidermal cells and lymphocytes to stimulate in the 
ELR and MLR, respectively. 
MATERIALS AND METHODS 
Lymphocyte isolation and M LR 
P eripheral blood mononuclear leukocytes (PBML) were obtained 
from healthy volunteers by Ficoll -Hypaque (Ficoll, S igma Chemical 
Co., St. Louis; MO; Hypaque, Winthrop Laboratories, New York) 
density gradient centrifugation [18) of fresh defibrinated venous blood. 
Where indicated P BML were separated in to T lymphocyte enriched 
a nd T -cell depleted (non-T) populations with a sheep erythrocyte 
rosetting technique as described [19]. In the MLR, 5 X 104 responder 
PBML were cultured wi th 5X 104 x-iiTadiated allogeneic stimulator 
PBML in 0.2 m.l of RPMI 1640 medium (Microbiological Associates, 
Walkerville, MD.) supplemented with 10% heat inactivated pooled 
human serum, a nd 2 mM L-glu tamine (complete RP MI). Afte r 6 days 
of cul ture in 10% C0 2 at 37°C, "H-thymidine (New England Nuclear, 
Boston, Mass.) was added (l 1-1Ci/well) , and the cells were hru-vested 18 
lU" later. 
Epidermal Cell Preparation and ELR 
As described previously [20], epidermal cell suspensions were pre-
pru·ed from keratotomed cadaver skin by exposure to 0.3% trypsin 
(Microbiological Associates, Walkerville, Md .) in 0.15 M NaCl, 5.4 mM 
KCI, 0.1% glucose a t pH 7.6. After 40 min at 37°C, the cells were 
resuspended in complete HPMI 1640 medium and fil tered t hrough 100 
gauge wi.J·e mesh . In t he E LR, 5 X 104 epidermal cells were co-cul tured 
wi th 5 X 10'' allogeneic lymphocytes under condi tions otherwise iden-
t ical to those of the MLR. 
P UVA Treatment 
Treatment of cells with PUVA consisted of a 1 hr incubation at 37°C 
with vru·ying concent rations of 8-MOP. T wo ml a liquots of ce lls were 
then placed in a 35 x 10 mm plastic Petri dish (Lu x Scient ific, Newbury 
Park, Ca.) covered wi th a 4-mm thickness of window glass, which 
a bsorbs light of wavelength less than 320 nm. A high-in tensity lamp 
(Sylvania tube #GB0-3824-231, Sylvania Corp., Danvers, Ma.) was 
used to ii-radiate the ceLls wi th 1.8 J / cm2 of neru· ul traviolet light (365 
nm) in a ligh t box used fo r treatment of patients. After t reatment, the 
ce lls were centri fuged at 300 Xg, resuspended in the medium described 
above, a nd immediately a liquoted in to microtiter wells for cul ture. T he 
inciden t UV A-light was moni to red using the radiometer supplied with 
the light box. This meter measures in the range between 320-380 nm 
[21). The Petri dishes were posit ioned on top of a foot stool placed on 
the fl oor of the l;Jox a nd always irrad iated at the same re lative distance 
from the ligh t bulbs. T o measm e the ftl tration effect of the Petri dish 
covers, the mediu m a nd the window glass, a por table photometer (H. 
Wald ma nn) which measures between 320-400 nm (H. Schaefer, per-
sonal communication) was used. T he cover of the Petri dish, 2 ml of 
medium a nd the window glass each decreases the incident dose of UVA 
about 10%. At the settings used, the dose of UVA reaching the cells 
was 1.8 J / cm2• About 1% of the light output is in the wavelengths 
between 290-320 nm (UVB ). Using a rad iometer (International Light), 
we determined that the window glass dec reases the incident. UVB by 
10% and the Lux Petri dish covers fur ther dec rease t.he UVB by 10-
250 MORHENN ET AL 
fold. Thus for every J /cm2 of UVA the cells receive less than 1 mJ/cm2 
UVB. The lamps were prewarmed for at least 5 min before use on the 
cells. 
X-Irradiation of Cells 
Where indicated stimulator cells were irradiated in a ""Cesium 
irradiator (Mark I, irradiator, JL Shepherd, Glendale, Ca.) with a dose 
of 3,000 rads to abol ish their capacity to proliferate and to make the 
reaction unidirectional. 
Assesmen.t of Cell Viability 
Cells were treated as indicated, centrifuged, resuspended in complete 
RPM! medium aliquoted into plastic test tubes (Falcon, Oxnard, CA) 
and incubated at 37°C. At intervals aliquots were removed and viability 
of epidermaJ cells and T and non-T lymphocytes was determined as 
described [22]. Briefly , 1 ml of cell suspension was incubated with .1 ml 
of .01% fluroescein diacetate, incubated for 5 min in the dark, washed 
with phosphate buffered saJine (PBS) and resuspended at 2 X 10" cells/ 
ml. One drop of th is suspension was placed on a slide with 51\ of 
ethidium bromide (0.04% in PBS) and examined immediately with a 
fluorescence microscope. Viable cells show green fluorescence whereas 
dead cells stain red. 
RESULTS 
Table I demonstrates that epidermal cells aTe potent stimu-
lators of allogeneic lymphocytes. As shown, stimula~ion in the 
ELR was prevented by PUV A pretreatment of the epidermal 
cells but not by 3,000 rads x-u-radiation. The effect of PUVA 
treatment was dependent on the concentration of 8-MOP used, 
and at the highest concentration tested (2.5 1-Lg/ ml) the reaction 
was completely blocked. ~re-incubation of epidermal cells with 
8-MOP but without subsequent exposure to UV A, had only a 
slight inhibitory effect on · the ELR. Exposure to UV A alone 
had a similar effect. The results of assays using 3H -thymidine 
incorporation as a meas'Lil'e of proliferation were paralleled by 
the number of blast cells counted microscopically (data not 
shown) . Comparable results have been obtained, in 6 experi-
ments. · . . . · 
PUV A also prevented stimulation by lymphocytes in the 
MLR, and representative data are shown in Table I. In this set 
of experiments, PBML that had been treated with 3,000 rads x-
u-radiation were either placed in culture immediately or further 
treated as ·indicated prior to cultme with allogeneic responder 
lymphocytes. Again, both 8-MOP and UV A were required for 
complete blockade, and inhibition was · observed at· the. same 
concentration of 8-MOP which blocked stimulation of epider-
mal cells in the ELR. 
In addition to its effect on stimulator cells, PUV A prevented 
responder lymphocytes from proliferating (Table II). In these 
reactions, all the stimulator cells were inactivated with 3,000 
rads x-irradiation and the responder cells were treated as indi-
cated. As can be seen, even the milder PUV A treatment pre-
vents the proliferative response of allogeneic lymphocytes. 
Thus, the concentration of photoactivated 8-MOP requu·ed for 
complete inhibition of response was less than the concentration 
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which abrogated the stimulatory capacity of lymphocytes or 
epidermal cells. Further, 1.8 J/cm2 UVA alone inhibited the 
proliferation of responder lymphocytes to 75% of control 
whereas this treatment decreased the stimulatory capacity of 
epidermal cells and lymphocytes only slightly (10% and 30%, 
respectively). 
One possible explanation for these results is that PUV A has 
a lethal effect on the cells stimulating and responding in the 
ELR and MLR. To assess this possibility, the viability ofPUVA 
treated epidermal cells and lymphocytes was monitored by 
staining viable cells with fluorescein diacetate and counterstain-
ing dead cells with ethidium bromide [22]. As shown in the 
Figure, the viability of epidermal cells was only minunally 
affected by PUV A. In contrast, PBML were sensitive to a 
variety of treatments, including PUV A, UV A and X-irradiation. 
Purified T cells were sensitive to all of the treatments, whereas 
non-T cells (primarily B~lymphocytes and monocytes) were 
particularly sensitive to PUV A and less sensitive to other 
treatments. Thus, more than 80% of initial lymphocyte popu-
lations were dead 48 homs after receiving the ·high dose of 
PUV A. Two experiments were done on cells from different 
donors and similar results were obtained each time. 
DISCUSSION 
In this report we have shown that immunologic reactions 
elicited by HLA-D antigens are inhibited by PUV A. Inhibition 
by PUV A of the MLR has recently been reported .[23]. The 
current work shows that the ELR as well .as the MLR is 
inhibited by PUV A and demonst~ates that PUV A affects both 
stimulator and responder cells. This inhibition may be ex-
plained by a second observation, that PUV A has a lethal effect 
on the cells stimulating or responding in the reactions studied, 
that is, lymphocytes, monocy.tes and possibly Lh cells of the 
epidermis. On the other hand, keratinocytes which represent 
the vast majority of epidermal cells are relatively, resistant to 
PUV A treatment. Since keratinocytes are usually exposed to a 
broad spectrum of UV irTadiation from the sun, the relative 
resistance of these cells to the toxic effects of l..IV light is not 
surprising. · 
The intracellular mechanism of the PUV A· effect is unknown. 
PUV A treatment of fibroblasts and epidermal cells causes 
inhibition of cellular DNA synthesis [2,3]. Therefore,. the ob--
served inhibition of .the ELR and MLR may be ,mediated by 
inhibition of DNA synthesis in the stimulator cells. Although 
it is standaTd procedure -in the unidirectional MLR to render 
stimulator cells incapable of detectable DNA synthesis by 
treating them with either x-iradiation [24] or mitomycin C 
[25], a low level of DNA synthesis undetectable by standard 
methods may be requu·ed for stimulation. Alternatively, PUV A 
either alone or in combination with the small amount of con-
taminating UVB may have an· effect similar to that previously 
reported for UVB, which is thought to inhibit stimulation in 
the MLR by preventing RNA synthesis [26]. A final possibility 
TABLE I. Effect of PUVA on the capacity of epidermal cells and lymphocytes to stimulate allogeneic lymphocytes · 
None 
Treatment of 
s timulator cells" 
3 000 rads x-i..rradiation 
o:5 f.Lg/ ml 8-MOP plus 1.8 J /cm2 UVA 
2.5 f.Lg/ ml8-MOP plus 1.8 J /cm' UVA 
2.5 f.Lg/ ml 8-MOP 
1.8 J /cm2 UVA 
Responses of lymphocytes to 
a llogeneic ep ide rmal cells 
Donor A Donor B 
tJ. cpm. ± SE'' 
47,150 ± 5052 43,069 ± 2630 
34,588 ± 3903 30,627 ± 4177 
18,331 ± 3380" 5,145 ± 825" 
198 ± 27" 44 ± u" 
29,004 ± 1325 33,647 ± 3566 
31,708 ± 4671 26,330 ± 1594 
Responses of lymphocytes to 
allogeneic lymphocytes 
Donor C Donor D 
tJ. cpm ±SE1' 
20,239 ± 1642 
578 ± 38" 
1,044 ± 155" 
16,316 ± 2688 
14,118 ± 904 
25,458 ± 2017 
138 ± 85" 
870 ± 218" 
19,203 ± 2430 
18,325 ± 1649 
" Epidermal cells were treated as indicated. The stimulator lymphocytes were treated with 3,000 rads x-i..rradiation and then either immediate ly 
put in to cultul'e or ful'ther treated with .5 f.Lg/ml photoactivated 8-MOP, 2.5 f.Lg/ ml photoactivated 8-MOP, 2.5 f.Lg/ ml 8-MOP or 1.8 J /cm2 UVA. 
" Response of lymphocytes cultured alone (475 cpm) subtracted to yield t.cpm. 
,. p < .01 by Student t-test. 
"p < .001 by Student t-test. 
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TABLE II. Effect of PUVA on the capacity of lymphocytes to 
resp ond in the MLR 
'T'reatme nt of 
responder cells(' 
None 
3,000 rads x- irradiation 
0.5 1-Lg/ml 8-MOP plus 
1.8 J/cm2 UVA 
2.5 1-Lg/ ml 8-MOP plus 
1.8 J /cm2 UVA 
2.5 1-Lg/ml 8-MOP alone 
1.8 J /cm2 UV A alone 
Pr.olife ration of responder lymphocytes to 
a llogene ic x- irradiated lymphocytes 
Donor E Donor I" 
t; CfJ/11 ± SE'' 
24,463 ± 912 22,458 ± 2,081 
4 71 ± 56' 203 ± 18'' 
375 ± 73" 711 ± 142'' 
-213 ± 81" 
21,806 ± 2133 
6,410 ± 1160" 
-36 ± 12'' 
18,401 ± 1,492 
6,017 ± 1,884" 
" Responder lymphocytes were pretreated as indicated, cocul tured 
with a llogeneic donor (E, F) lymphocytes and proliferation measured 
at day 7. 
" Proliferation of responder lymphocytes cultured a lone (912 cpm) 
s ubtracted to yield Acpm. 
"p < .01 by Student t-test. 
"p < .001 by Student t-test. 
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Viability of epidermal cells, T and non-T lymphocytes following 
various forms of treatment. Brachets indicate standard error of the 
mean . Populations of epidermal cells, T cells and non-T cells were 
treated as indicated. In D, the cells were treated with 2.5 1-Lg/ ml 8-MOP 
o nly. Following treatment, viability was determined at 0, 4, 24 and 48 
hi by staining cells with flu orescein diacetate and ethidium bromide 
(0--0 epidermal cells, •--• T lymphocytes, 6--6 non-T lym-
p hocytes). 
is that the effects observed here are not related to a primary 
central metabolic insult, bu t may be the resul t of interaction 
between PUV A and the cell surface membrane, possibly involv-
ing alteration of HLA-D antigens. It should be noted that -
alteration of the cell membrane might be an indirect result of 
a ny of these proposed mechanisms. 
Regardless of the precise subcellular site of PUV A action, the 
data indicate that lymphocytes, monocytes, and possibly Lh 
cells are more susceptible to this treatment than the predomi-
nant epidermal cell, th e keratinocyte. Since the Lh represents 
such a small fraction of the total epidermal cell population, a 
selective lethal effect of PUV A on this cell type would not be 
apparent from our viability studies on total epidermal cells. 
Recent evidence suggests that the majority of Lh cells in the 
epidermis are bone marrow derived [27] and that they probably 
play a vital role in the afferent limb of the immune response 
leading to contact sensitization [28]. Moreover, PUV A treat-
ment abolishes the delayed hypersensitivity response at sites 
previously sensitized to an antigen [29] which indicates that Lh 
cells may be inactivated or killed by PUV A therapy. It is 
possible, therefore, that the clinical effectiveness of PUV A may 
be due to its toxic effect on Lh cells or other immunocompetent 
cells in the skin, which results in inhibition of cell-mediated 
immune functions. Proof of this hypothesis of PUV A action 
would be of considerable interest since it would confmn that 
the immune system has a direct role in the pathogenesis of 
psoriasis as well as other skin disorders. 
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and Dr. E.M. Farber for his support and encouragement 
REFERENCES 
1. Parrish JA, Fitzpatrick L, T annebaum MA: Photochemotherapy of 
psoriasis with oral methoxsalen and long-wave ul traviolet light. 
N Engl J Med 291:1207-1221, 1974 
2. Baden HP, Farrington JM, Delhanty JDA, Pathak MA: DNA 
synthesis in normal a nd xeroderma pigmentosum fibrob lasts 
following treatment with 8-methoxypsoralen and long-wave ul-
traviolet light. Biochim Biophys Acta 262:247-255, 1972. 
3. Walter JF, Voorhees JJ, Kelsey WH, Duell EA: Psoralen plus black 
light inhibits epiderma l DNA synthesis. Arch Dermatol 107:861-
865, 1973 
4. Parrish JA, Fitzpatrick TB, Shea C, Pathak MA: P hotochemoth-
erapy of viti.ligo use of orally administered psoralens and a high 
in tensity long-wave ultraviolet light system. Arch Dermatol 112: 
1531-1534, 1976 
5. Weissman I, Hoffman C, Wagner G, Plewig G, Braun-Falco 0: 
PUV A-Therapy for alopecia areata: Arch Dermatol Res 262:333-
336, 1978 
6. Gilchrist BA, Parrish JA, Tannebaum L, Hayes HA, Fitzpatrick 
TB: Oral methoxsalen photochemotherapy of mycosis fungo ides. 
Cancer 38:683-689, 1976 
7. Ortonne JP, T hivolet J , Sannwald C: Oral photochemotherapy in 
the treatment of lichen planus. Br J Dermatol 99:77-88, 1978 
8. Betterle C, Prete GFD, Peserico A, Bersani G, Caracciolo F, Trio-
sotto T: Autoantibodies in vitiligo. Arch Dermatol 112:1328, 1976 
9. Thies W: Vergleichende histologische-un tersuchungen bei alopecia 
areata und narbig-atrophisierenden a lopecien. Arch Klin Exp 
Dermatol 227: 54 1-549, 1966 
10. Morison WL, Parrish JA, Epstein JH: Photoimmunology. Arch 
Dermatol 115:350-355, 1979 
11. Barnsta ble CJ, Jones EA, Crumpton MJ: Isolation, structure and 
genetics of HLA-A, -B, -C and DRw (Ia)antigens. Br Med Bull 
34:241-246, 1978 
12. Winchester RJ, Meyers PA, Broxmeyer HE, Wang _CY, Moore 
MAS, Kunkel HG: Inhibition of human erythropoetic colony 
formation in cul ture by treatment with Ia ant isera. J Exp Med 
148:613-618, 1978 
13. Sting! G, Katz SI, Abelson LD, Mann DL: Immunofluorescent 
detection of human B ce ll alloantigens on S-Ig-positive lympho-
cytes and epidermal Langerhans cells. J Immunol 120:661-664, 
1978 
14. Tweel van den JG, Blusse van Oud Alblas A, Keuning JJ, Goulmy 
E, Termijtelen A, Bach ML, Rood van JJ: Typing for MLC (LD): 
L Lymphocytes from cousin-marriage offspring as typing cells. 
Transplant Proc 5:1535-1538, 1973 
15. Cochrum KC, Main RK, Kountz SL: A new matching technique: 
T he mixed skin cell-leukocyte reaction (MSLR). Smgery (St. 
Louis) 70:97-102, 1971 
16. Levis WR, Miller EA: Leukocyte/ skin cul tures as a measure of 
histocompatibili ty in man. Lancet 2:357-360, 1972 
17. Hirschberg H, Thorsby E : T he presence of HLA-0 determinants 
on human skin cells. T ransplantation (Baltimore) 21:343-347, 
1976 
18. Boyum A: Separation of leukocytes from blood and bone marrow. 
Scand J Clin Lab Invest 21(897) :1-106, 1968 
19. Gmelig-Meyling F, Ballieux RE: S implified procedur e for the sep-
ara tion of human T and non-T cells. Vox Sang 33:5-8, 1977 
20. Liu S, Karasek M: Isolation and growth of adult human epidermal 
keratinocytes in cell culture. J Invest Dermatol 71:157-162, 1978 
2L Parrish JA, Fitzpatrick T: PUV A Technician Manual 
22. Bodme1· W, T ripp M, Bodmer J: Application .of flu orochromatic 
cytotoxicity assay to human leukocyte typ ing. In Histocompati-
bility T esting. Edited by ES Curtoni, PL Mattiuz and RM Tosi. 
The Williams Wilkins Co, Copenhagen, 1967, pp 34 1-350 
252 MORHENN ET AL 
23. Levis WR, Kraemer KR: Inhibi t ion of mixed leukocyte culture 
reaction by 8-methoxypsoralen and longwavelength ultraviolet 
radiation. Clin. Res 27:243A, 1979 
24 . B radley BA, Edward JM, Franks D: Histocompatibility phenotyp-
ing by the mixed lymphocyte reactions. Tissue Antigens 3:340-
347, 1973 
25. Bach FH, Voynow NK: One-way stimula tion in mixed leukocyte 
cul tures. Science (Wash DC) 153:545-547, 1966 
26. Lindahl-Kiessling K , Safwenberg J : Mechanism of s timulation in 
the mixed lymphocyte culture, Proc. S ixth Leukocyte Culture 
Conference. Edited by MR Schwarz. Academic Press, NY, 1972, 
Vol. 75, No . 3 
pp 623-635 
27. K atz SI, Tama ki K, Sachs D: Epidermal Langerhans cells are 
derived from and are repopulated by mobile precursor cells which 
originate in bone marrow. Clin R es 27:446A, 1979 
28. S ilberberg I: Apposition of mononuclear ce lls to Langerhans cells 
in contac t allergic reaction. Acta Dermatovenerol (Stockh) 53: 1-
12, 1973 
29. Morison WL, Woehler ME, Parrish JA: PUVA and systemic im-
munosuppression in guinea pigs. Abstract Joint Meeting of t he 
Soc Invest Dermatol and European Soc D ermatol R es Amer-
sterda m, June 1979 
